The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gline Matthew since 2022.
This trader's CIK number is 1750094.
At the time of last reporting, Gline Matthew was the CEO of Roivant Sciences Ltd.. (stock ticker symbol ROIV).
Also see all insider trading activities at Roivant Sciences Ltd..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ROIV | 0 | $0 | 1,983,257 | $23,382,600 | 1,940,579 | $5,967,500 |
| 2023 | ROIV | 0 | $0 | 0 | $0 | 144,733 | $0 |
| 2022 | ROIV | 0 | $0 | 492,350 | $2,220,730 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-09-23 | ROIV | Option Ex | 1,550,000 | 3.85 | 5,967,500 |
| 2024-09-23 | ROIV | Sale | 1,983,257 | 11.79 | 23,382,600 |
| 2024-03-30 | ROIV | Option Ex | 390,579 | .00 | 0 |
| 2023-12-27 | ROIV | Option Ex | 38,453 | .00 | 0 |
| 2023-09-27 | ROIV | Option Ex | 17,762 | .00 | 0 |
| 2023-08-27 | ROIV | Option Ex | 12,088 | .00 | 0 |
| 2023-07-27 | ROIV | Option Ex | 23,149 | .00 | 0 |
| 2023-05-27 | ROIV | Option Ex | 53,281 | .00 | 0 |
| 2022-10-25 | ROIV | Sale | 19,276 | 4.40 | 84,814 |
| 2022-09-23 | ROIV | Sale | 21,053 | 3.07 | 64,632 |
| 2022-08-24 | ROIV | Sale | 20,009 | 3.71 | 74,233 |
| 2022-07-25 | ROIV | Sale | 20,455 | 4.33 | 88,570 |
| 2022-06-23 | ROIV | Sale | 19,855 | 4.34 | 86,170 |
| 2022-05-20 | ROIV | Sale | 139,791 | 3.70 | 517,226 |
| 2022-04-25 | ROIV | Sale | 8,509 | 3.84 | 32,674 |
| 2022-03-30 | ROIV | Sale | 33,686 | 4.84 | 163,040 |
| 2022-03-25 | ROIV | Sale | 35,386 | 5.06 | 179,053 |
| 2022-03-18 | ROIV | Sale | 82,006 | 5.13 | 420,690 |
| 2022-03-07 | ROIV | Sale | 92,324 | 5.52 | 509,628 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gline Matthew (CEO of Roivant Sciences Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.